# Michael Xue

> Michael Xue is a seed investor at Morningside backing Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Morningside](https://shizune.co/investors/profile/morningside-technology-ventures)
- Total investments: 2
- Last investment: Aug 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/michael-xue-021a8339/?originalSubdomain=cn

Michael Xue is a seed investor at Morningside focused on Biotechnology. Michael Xue is the Managing Director of Morningside Venture Capital.

## Investment focus

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Epigenic Therapeutics | Epigenic Therapeutics is a biotech firm that offers gene editing therapy. | $32M | Series A | Aug 29, 2023 |  |
| Epigenic Therapeutics | Epigenic Therapeutics is a biotech firm that offers gene editing therapy. | $20M | Seed | Aug 06, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [FountainBridge Capital](https://shizune.co/investors/profile/fountainbridge-capital) — VC Fund, 1 deal together
- [Kingray Capital](https://shizune.co/investors/profile/kingray-capital) — VC Fund, 1 deal together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 1 deal together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 1 deal together
- [Taiyu Investment](https://shizune.co/investors/profile/taiyu-investment) — VC Fund, 1 deal together
- [Taiyu Investment](https://shizune.co/investors/profile/tigeryeah-capital) — VC Fund, 1 deal together

## About Morningside

VC Fund · Shanghai, China

Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering commitment to acting ethically.Based in the greater Boston area, our team of entrepreneurial investment professionals has deep experience in life sciences, digital health,AI, materials and technology.Founded in 1986 as a family office for the Chan family, charitable commitments to education, research and healthcare include the Harvard T.H. Chan School of Public Health, the UMass Chan Medical School, and the MIT Morningside Academy for Design.

5 contacts available at Morningside.

| Name | Title | Profile |
| --- | --- | --- |
| Anthony Aiudi | Investment Professional | https://shizune.co/investors/profile/anthony-aiudi |
| Mick Sawka | Investment Manager | https://shizune.co/investors/profile/mick-sawka |
| Gerald Chan | Co-Founder, Investment Director & Board Member | https://shizune.co/investors/profile/qin-liu-f6a9 |
| Justin Burns | Investment Professional | https://shizune.co/investors/profile/justin-burns-de33 |
| Michael Xue | Managing Director | https://shizune.co/investors/profile/michael-xue-bf20 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Michael Xue invest in?

Michael Xue invests primarily in Biotechnology startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Michael Xue last invest?

The most recent investment recorded for Michael Xue closed in Aug 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co